1.b. For animal studies, include a statement about sample size estimate even if no statistical methods were used.
2. Describe inclusion/exclusion criteria if samples or animals were excluded from the analysis. Were the criteria pre--established?
3. Were any steps taken to minimize the effects of subjective bias when allocating animals/samples to treatment (e.g. randomization procedure)? If yes, please describe.
For animal studies, include a statement about randomization even if no randomization was used.
4.a. Were any steps taken to minimize the effects of subjective bias during group allocation or/and when assessing results (e.g. blinding of the investigator)? If yes please describe. Do the data meet the assumptions of the tests (e.g., normal distribution)? Describe any methods used to assess it.
Is there an estimate of variation within each group of data?
Is the variance similar between the groups that are being statistically compared?
Yes. We used appropriate statistical method.
Yes. The data meet the assumptions of the tests.
Yes.
YOU MUST COMPLETE ALL CELLS WITH A PINK BACKGROUND ê
We designed proof of concept human study and included 6 subjects to the study. After seeing the significant effect, we decided to publish it in its current form.
We included 10 animals in each group and have also verified the results in an independent experiment.
No samples were excluded from the analysis.
We have separeted animals in two two group and suplemented one group with the cocktail to see its effect on liver fat. The lipidomics were performed by a staff scientist with blinded samples.
We have separeted animals in two two group and suplemented one group with the cocktail to see its effect on liver fat. The person who handled the mice did not perform the lipidomics analyses of the samples.
The lipidomics analyses were performed with blinded samples. The clinical chemistry measurements were performed by a professional accredited clinical chemistry laboratory with blinded sampes. The measurement of liver fat were performed by specialized clinical staff without knowing anything about the ongoing clinical trial.
We have not consider blinding of the investigator. The reason is that we wanted the same person to perform all la gavage treatments, in order to minmize variation. 
Data
the data were obtained and processed according to the field's best practice and are presented to reflect the results of the experiments in an accurate and unbiased manner. figure panels include only data points, measurements or observations that can be compared to each other in a scientifically meaningful way. graphs include clearly labeled error bars for independent experiments and sample sizes. Unless justified, error bars should not be shown for technical replicates. if n< 5, the individual data points from each experiment should be plotted and any statistical test employed should be justified Please fill out these boxes ê (Do not worry if you cannot see all your text once you press return) a specification of the experimental system investigated (eg cell line, species name).
Each figure caption should contain the following information, for each panel where they are relevant:
Captions
The data shown in figures should satisfy the following conditions:
Source Data should be included to report the data underlying graphs. Please follow the guidelines set out in the author ship guidelines on Data Presentation. a statement of how many times the experiment shown was independently replicated in the laboratory.
Any descriptions too long for the figure legend should be included in the methods section and/or with the source data.
Please ensure that the answers to the following questions are reported in the manuscript itself. We encourage you to include a specific subsection in the methods section for statistics, reagents, animal models and human subjects.
In the pink boxes below, provide the page number(s) of the manuscript draft or figure legend(s) where the information can be located. Every question should be answered. If the question is not relevant to your research, please write NA (non applicable).
B--Statistics and general methods
7. Identify the source of cell lines and report if they were recently authenticated (e.g., by STR profiling) and tested for mycoplasma contamination. 11. Identify the committee(s) approving the study protocol.
12. Include a statement confirming that informed consent was obtained from all subjects and that the experiments conformed to the principles set out in the WMA Declaration of Helsinki and the Department of Health and Human Services Belmont Report.
13. For publication of patient photos, include a statement confirming that consent to publish was obtained.
14. Report any restrictions on the availability (and/or on the use) of human data or samples. The mice were housed at the Univ of Gothenburg animal facility (Lab of Exp Biomed) and supervised by university veterinarians and professional staff. The experiments were approved by the Gothenburg Ethical Committee on Animal Experiments. The mice were on C57BL/6J background from Janvier Labs, 8 weeks old when they were fed high--fat diet and 10 weeks when they started to receive la gavage feeding. Only males were used. The diets are defined in the manuscript.
N/A
The ARRIVE Guidelines (Animal Research: Reporting In Vivo Experiments) are followed. This detailed information is included in the application for the animal ethics. Thus, all experiments are well documented.
The clinical study was approved by the Gothenburg Human Ethical Committee, and submitted to ClinicalTrials. Gov with the identifier NCT02599038.
Informed consents were obtained from all subjects and the experiments conformed to the principles set out in the WMA Declaration of Helsinki and the Department of Health and Human Services Belmont Report.
